ArticleSchizophrenia bulletin2024

Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis.

Cassandra M J Wannan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.